Results 181 to 190 of about 1,274,130 (253)

Artificial Intelligence and Access to Justice at the ‘Shop Front’: The Potential and Limitations of Meeting Legal Need Through Technology

Australian Journal of Social Issues, EarlyView.
ABSTRACT In Australia, governments fund Community Legal Centres (CLCs) as part of the legal assistance sector (LAS) to meet the ‘legal needs’ of people experiencing disadvantage who cannot afford private legal services. Persistent unmet demand for CLCs is well‐documented. As artificial intelligence (AI) is increasingly used in private legal practice to
Catherine Hastings, Art Cotterell, Farzana Bruce   +2 more
wiley   +1 more source

Magnesium‐Retention Assisted Synthesis of High‐Performance Zintl Thermoelectrics

Angewandte Chemie, EarlyView.
Mg volatilization and chemical instability during high‐temperature synthesis hinder the scalable fabrication of Mg‐based thermoelectrics. Here, a magnesium‐retention assisted synthesis (MRAS) strategy stabilizes Mg using a sacrificial Mg reservoir and an inert‐gas‐regulated melting environment.
Boxuan Hu, Xiao‐Lei Shi, Tianyi Cao, Nanhai Li, Chao Zhang, Sen Wang, Siqi Liu, Meng Li, Dmitri Golberg, Zhi‐Gang Chen   +9 more
wiley   +2 more sources

Distinct Exercise Response Patterns in Patients With Heart Failure With Preserved Ejection Fraction. [PDF]

J Am Heart Assoc
De Schutter S, Pugliese NR, Meems LMG, Moura-Ferreira S, De Biase N, Del Punta L, Masi S, Stassen J, Herbots L, Claessen G, Van de Heyning CM, Verwerft J, Gevaert AB.   +12 more
europepmc   +1 more source

Refining a preclinical model of viral myocarditis in accordance with biotech standards

Animal Models and Experimental Medicine, EarlyView.
This study aimed to refine a murine model of Coxsackievirus B3‐induced myocarditis by integrating dietary and imaging innovations to improve animal welfare, data quality, and clinical applicability. The refined diet significantly reduced animal health burden, reduced weight loss, and stabilized blood glucose during development of cardiac inflammation ...
Jonas Stewen, Julia Riedesel, Juliane Stein, Brandon H. Greene, Svenja Rohde, Sonja Suess, Bjoern Keiner, Priya Panjwani, Padmapriya Ponnuswamy, Juan E. Camacho Londoño   +9 more
wiley   +1 more source

Heart Failure With Preserved Ejection Fraction: A Practical, Stepwise Guide to Evidence-Based Therapy in 2026. [PDF]

Cureus
Chabalout MN, Alazzeh M, Othman D, Virk JPS.   +3 more
europepmc   +1 more source

Aortic valve disease: Novel animal models for advancing our understanding of the underlying mechanisms

Animal Models and Experimental Medicine, EarlyView.
Due to the complex pathophysiology of aortic valve disease (AVD) and the resulting lack of effective pharmacotherapy, existing animal models are valuable research tools, but each has its own strengths and limitations. This review systematically surveys the major AVD models, compares their induction methods, pathological features, advantages and ...
Liya Hou, Xue Liu, Wangxing Hu, Xianbao Liu, Wei Zhu   +4 more
wiley   +1 more source

Longitudinal phenotyping of heart failure with preserved ejection fraction identifies early- and end-stage disease states. [PDF]

Open Heart
Brown S, Soltani F, Wu J, Ryan M, Bernstein BS, Tam To B, Searle T, Rizvi M, Fairhurst N, Kaye G, Baral R, Vijayakumar D, Mehta D, Khawaja Z, Chowienczyk P, Teo J, Dobson RJ, Bromage DI, Carr-White G, Lüscher TF, Vazir A, McDonagh TA, Webb J, Miller CA, Shah AM, Biswas D, O'Gallagher K.   +26 more
europepmc   +1 more source

Silk Fibroin for Cardiovascular Medical Devices: Review of Material Properties, Applications, and Clinical Potential

Advanced NanoBiomed Research, EarlyView.
Silk fibroin is an attractive natural biomaterial that can be engineered into diverse cardiovascular constructs, including vascular grafts, cardiac patches, heart valves, and stent coatings. Its tunable biological and mechanical properties have driven substantial preclinical progress; however, widespread clinical translation in cardiovascular ...
Mahsa Haghighattalab, Matt Govendir, Kristina Andelovic, Zachary Och, Fatemeh Karimi, Munira Xaymardan, Tomasz Jungst, Jelena Rnjak‐Kovacina, Nona Farbehi   +8 more
wiley   +1 more source

TSC2-mTORC1 signaling in murine Heart failure with preserved Ejection fraction (HFpEF)

TSC2-MTORC1 SIGNALING IN MURINE HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) TSC2-mTORC1 signaling in murine Heart failure with preserved Ejection fraction (HFpEF) / Fu, Shu (Rights reserved) (-
Fu, Shu
core  

Venous vascular pharmacology: how does it contribute to heart failure with preserved ejection fraction? [PDF]

Eur Heart J Cardiovasc Pharmacother
Lineham J, Dagan M, Wang B, Kaye DM.
europepmc   +1 more source